Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways

Molecular Psychiatry

Volumn 21, Issue 5, 2016, Pages 665-679

  Howe, A S ^a   ButtenschOn H N ^b,c   Bani Fatemi, A ^a   Maron, E ^d,e   Otowa, T ^f   Erhardt, A ^g   Binder, E B ^g   Gregersen, N O ^b,c   Mors, O ^c,h   Woldbye, D P ⁱ   Domschke, K ^j   Reif, A ^k   Shlik, J ^l   Kks, S ^e   Kawamura, Y ^m   Miyashita, A ^m   Kuwano, R ⁿ   Tokunaga, K ^f   Tanii, H ^o   Smoller, J W ^p   Sasaki, T ^q   Koszycki, D ^l,r   De Luca, V ^a   more..

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b AARHUS UNIVERSITY   (Denmark)

^c Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF TARTU   (Estonia)

^f UNIVERSITY OF TOKYO   (Japan)

^g MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j UNIVERSITY OF WÜRZBURG   (Germany)

^k GOETHE UNIVERSITY   (Germany)

^l UNIVERSITY OF OTTAWA   (Canada)

^m Sakae Seijinkai Hospital   (Japan)

ⁿ NIIGATA UNIVERSITY   (Japan)

^o MIE UNIVERSITY   (Japan)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

^q UNIVERSITY OF TOKYO   (Japan)

^r INSTITUT DU SAVOIR MONTFORT   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CATECHOL METHYLTRANSFERASE; HTR2A PROTEIN; MAOA PROTEIN; NPSR1 PROTEIN; TMEM132D PROTEIN; UNCLASSIFIED DRUG;

AGORAPHOBIA; ALLELE; ARTICLE; ASIAN; COMORBIDITY; EUROPEAN; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENOTYPE; HUMAN; MANTEL HAENSZEL TEST; META ANALYSIS; PANIC; POPULATION GENETICS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; ANXIETY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

ANXIETY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PANIC DISORDER; POLYMORPHISM, GENETIC;

EID: 84941888802     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.138     Document Type: Article

References (166)

1. Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63: 415-424
2. Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 2005; 62: 182-189
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Publishing: Washington, DC, USA, 2013
4. Tsusang M, Domschke K, Jerskey BA, Lyons MJ. Agoraphobic behavior and panic attack: a study of male twins. J Anxiety Disord 2004; 18: 799-807
5. Noyes R Jr, Crowe RR, Harris EL, Hamra BJ, McChesney CM, Chaudhry DR. Relationship between panic disorder and agoraphobia: a family study. Arch Gen Psychiatry 1986; 43: 227-232
6. Maron E, Hettema JM, Shlik J. Advances in molecular genetics of panic disorder. Mol Psychiatry 2010; 15: 681-701
7. Domschke K, Deckert J. Genetics of anxiety disorders - status quo and quo vadis. Curr Pharm Des 2012; 18: 5691-5698
8. Tambs K, Czajkowsky N, Røysamb E, Neale MC, Reichborn-Kjennerud T, Aggen SH et al. Structure of genetic and environmental risk factors for dimensional representations of DSM-IV anxiety disorders. Br J Psychiatry 2009; 195: 301-307
9. Logue MW, Bauver SR, Knowles JA, Gameroff MJ, Weissman MM, Crowe RR et al. Multivariate analysis of anxiety disorders yields further evidence of linkage to chromosomes 4q21 and 7p in panic disorder families. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 274-280
10. Hodges LM, Fyer AJ, Weissman MM, Logue MW, Haghighi F, Evgrafov O et al. Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder. Neuropsychopharmacology 2014; 39: 2423-2431
11. Quast C, Altmann A, Weber P, Arioth J, Bader D, Heck A et al. Rare variants in TMEM132D in a case-control sample for panic disorder. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 896-907
12. Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S et al. TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 2011; 16: 647-663
13. Gregersen N, Dahl HA, Buttenschøn HN, Nyegaard M, Hedemand A, Als TD et al. A genome-wide study of panic disorder suggests the amiloride-sensitive cation channel 1 as a candidate gene. Eur J Hum Genet 2012; 20: 84-90
14. Gregersen NO, Buttenschon HN, Hedemand A, Dahl HL, Kristensen AS, Clementsen B et al. Are TMEM genes potential candidate genes for panic disorder?. Psychiatr Genet 2014; 24: 37-41
15. Kawamura Y, Otowa T, Koike A, Sugaya N, Yoshida E, Yasuda S et al. A genomewide CNV association study on panic disorder in a Japanese population. J Hum Genet 2011; 56: 852-856
16. Otowa T, Tanii H, Sugaya N, Yoshida E, Inoue K, Yasuda S et al. Replication of a genome-wide association study of panic disorder in a Japanese population. J Hum Genet 2010; 55: 91-96
17. Otowa T, Yoshida E, Sugaya N, Yasuda S, Nishimura Y, Inoue K et al. Genomewide association study of panic disorder in the Japanese population. J Hum Genet 2009; 54: 122-126
18. Otowa T, Kawamura Y, Nishida N, Sugaya N, Koike A, Yoshida E et al. Metaanalysis of genome-wide association studies for panic disorder in the Japanese population. Transl Psychiatry 2012; 2: e186
19. Gratacòs M, Costas J, de Cid R, Bayés M, González JR, Baca-García E et al. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 808-816
20. Nivard MG, Mbarek H, Hottenga JJ, Smit JH, Jansen R, Penninx BW et al. Further confirmation of the association between anxiety and CTNND2: replication in humans. Genes Brain Behav 2014; 13: 195-201
21. Quast C, Reif A, Brückl T, Pfister H, Weber H, Mattheisen M et al. Sex-specific association of variants in the AKR1C1 gene with dimensional anxiety in patients with panic disorder: additional evidence for the important of neurosteroids in anxiety?. Depress Anxiety 2014; 31: 843-850
22. Haaker J, Lonsforf TB, Raczka KA, Mechias ML, Gartmann N, Kalisch R et al. Higher anxiety and larger amygdala volumes in carriers of a TMEM132D risk variant for panic disorder. Transl Psychiatry 2014; 4: e357
23. Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, Müller-Myhsok B et al. Replication and meta-Analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry 2012; 2: e156
24. Domschke K, Deckert J, O'Donovan MC, Glatt SJ. Meta-Analysis of COMT val158met in panic disorder: ethnic heterogeneity and sex specificity. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 667-673
25. Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP et al. Meta-Analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 786-793
26. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P et al. Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Mol Psychiatry 2011; 16: 938-948
27. Okamura N, Hashimoto K, Iyo M, Shimizu E, Dempfle A, Friedel S et al. Sexspecific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attentiondeficit/ hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1444-1448
28. Donner J, Haapakoski R, Ezer S, Melén E, Pirkola S, Gratacòs M et al. Assessment of neuropeptide S system in anxiety disorders. Biol Psychiatry 2010; 68: 474-483
29. Bornstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixedeffect and random-effects models for meta-Analysis. Res Syn Methods 2010; 1: 97-111
30. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-Analysis. J R Statist Soc 2009; 172: 137-159
31. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101
32. Core Team R. R: A Language and Environment for Statistical and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2015, http://www.R-project.org/.
33. Viechtbauer W. Conducting meta-Analyses in R with the metafor package. J Stat Soft 2010; 36: 1-48
34. Klauke B, Deckert J, Zwanzger P, Baumann C, Arolt V, Pauli P et al. Neuropeptide S receptor gene (NPSR) and life events: G õ E effects on anxiety sensitivity and its subdimensions. World J Biol Psychiatry 2014; 15: 17-25
35. Raczka KA, Gartmann N, Mechias ML, Reif A, Büchel C, Deckert J et al. A neuropeptide S variant associated with overinterpretation of fear reactions: a potential neurogenetic basis for catastrophizing. Mol Psychiatry 2010; 17: 468
36. Pugla A, Ruzza C, Rizzi A, Guerrini R, Calo G. Anxiolytic and panicolytic effect of neuropeptide S in the mouse elevated T-maze. Eur J Neurosci 2012; 36: 3531-3137
37. Maron E, Shlik J. Serotonin function in panic disorder: important, but why?. Neuropsychopharmacology 2006; 31: 1-11
38. McKinney J, Knappskog PM, Haavik J. Different properties of the central and peripheral forms of human tryptophan hydroxylase. J Neurochemistry 2005; 92: 311-320
39. Freitag CM, Domschke K, Rothe C, Lee YJ, Hohoff C, Gutknecht L et al. Interaction of serotonergic and noradrenergic gene variants in panic disorder. Psychiatr Genet 2006; 16: 59-65
40. Baumann C, Klauke B, Weber H, Domschke K, Zwanzger P, Pauli P et al. The interaction of early life experiences with COMT val158met affects anxiety sensitivity. Genes Brain Behav 2013; 12: 821-829
41. Klauke B, Deckert J, Reif A, Pauli P, Zwanzger P, Baumann C et al. Serotonin transporter gene and childhood trauma - a G õ E effect on anxiety sensitivity. Depress Anxiety 2011; 28: 1048-1057
42. Laas K, Reif A, Akkermann K, Kiive E, Domschke K, Lesch KP et al. Interaction of the neuropeptide S receptor gene Asn107Ile variant and environment: contribution to affective and anxiety disorders, and suicidal behaviour. Int J Neuropsychopharmacol 2014; 17: 541-552
43. Domschke K, Tidow N, Schrempf M, Schwarte K, Klauke B, Reif A et al. Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation?. Prog Neuropsychopharmacol Biol Psychiatry 2013; 46: 189-196
44. Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambrée O et al. Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?. Int J Neuropsychopharmacol 2012; 15: 1217-1228
45. Bayles R, Baker EK, Jowett JB, Barton D, Esler M, El-Osta A et al. Methylation of the SLC6A2 gene promoter in major depression and panic disorder. PLoS One 2013; 8: e83223
46. Muiños-Gimeno M, Espinosa-Parrilla Y, Guidi M, Kagerbauer B, Sipilä T, Maron E et al. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry 2011; 69: 526-533
47. Roberson-Nay R, Kendler KS. Panic disorder and its subtypes: a comprehensive analysis of panic symptom heterogeneity using epidemiological and treatment seeking samples. Psychol Med 2011; 41: 2411-2421
48. Kircanski K, Phil C, Craske MG, Epstein AM, Wittchen HU. Subtypes of panic attacks: a critical review of the empirical literature. Depress Anxiety 2009; 26: 878-887
49. Tibi L, van Oppen P, Adberka IM, van Balkom AJ, Batelaan NM, Spinhoven P et al. Examining determinants of early and late age at onset in panic disorder: an admixture analysis. J Psychiatry Res 2013; 47: 1870-1875
50. Strug LJ, Suresh R, Fyer AJ, Talati A, Adams PB, Li W et al. Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry 2010; 15: 166-176
51. Rothe C, Gutknecht L, Freitag C, Tauber R, Mössner R, Franke P et al. Association of a functional 1019C4G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int J Neuropsychopharmacol 2004; 7: 189-192
52. Subaran RL, Talati A, Hamilton SP, Adams P, Weissman MM, Fyer AJ et al. A survey of putative anxiety-Associated genes in panic disorder patients with and without bladder symptoms. Psychiatr Genet 2012; 22: 271-278
53. Nakamura M, Ueno S, Sano A, Tanabe H. Polymorphisms of the human homologue of the Drosophila white gene are associated with mood and panic disorders. Mol Psychiatry 1999; 4: 155-162
54. Schumacher J, Abou Jamra R, Becker T, Klopp N, Franke P, Jacob C et al. Investigation of the DAOA/G30 locus in panic disorder. Mol Psychiatry 2005; 10: 428-429
55. Koido K, Eller T, Kingo K, Kks S, Traks T, Shlik J et al. Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. J Psychiatr Res 2010; 44: 275-277
56. Otowa T, Tochigi M, Kawamura Y, Sugaya N, Yoshida E, Inoue K et al. An association analysis of Per2 with panic disorder in the Japanese population. J Hum Genet 2011; 56: 748-750
57. Thoeringer CK, Binder EB, Salyakina D, Erhardt A, Ising M, Unschuld PG et al. Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. J Psychiatr Res 2007; 41: 579-584
58. Koido K, Traks T, Baltšev R, Eller T, Must A, Koks S et al. Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder. Transl Psychiatry 2012; 2: e152
59. Smoller JW, Gallagher PJ, Duncan LE, McGrath LM, Haddad SA, Holmes AJ et al. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biol Psychiatry 2014; 76: 902-910
60. Hettema JM, An SS, Neale MC, van Den Oord EJ, Kendler KS, Chen X. Lack of association between the amiloride-sensitive cation channel 2 (ACCN2) gene and anxiety spectrum disorders. Psychiatr Genet 2008; 18: 73-79
61. Maron E, Nikopensius T, Kks S, Altmäe S, Heinaste E, Vabrit K et al. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 2005; 15: 17-24
62. Ho HP, Westberg L, Annerbrink K, Olsson M, Melke J, Nilsson S et al. Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinology 2004; 29: 1138-1141
63. Bandelow B, Saleh K, Pauls J, Domschke K, Wedekind D, Falkai P. Insertion/ deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: a sex-specific effect?. World J Biol Psychiatry 2010; 11: 66-70
64. Bayoglu B, Cengiz M, Karacetin G, Uysal O, Kocabasoglu N, Bayar R et al. Genetic polymorphism of angiotensin I-converting enzyme (ACE), but not angiotensin II type I receptor (ATr1), has a sex-specific role in panic disorder. Psychiatry Clin Neurosci 2012; 66: 130-137
65. Olsson M, Annerbrink K, Westberg L, Melke J, Baghaei F, Rosmond R et al. Angiotensin-related genes in patients with panic disorder. Am J Med Genet B Neuropsychiatr Genet 2004; 127B: 81-84
66. Shimizu E, Hashimoto K, Kobayashi K, Mitsumori M, Ohgake S, Koizumi H et al. Lack of association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and panic disorder in humans. Neurosci Lett 2004; 363: 81-83
67. Erhardt A, Lucae S, Kern N, Unschuld PG, Ising M, Lieb R et al. Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks. Mol Psychiatry 2008; 13: 242-243
68. Gulec-Yilmaz S, Gulec H, Dalan AB, Cetin B, Timirci-Kahraman O, Ogut DB et al. The relationship between ACE polymorphism and panic disorder. In Vivo 2014; 28: 885-889
69. Kucharska-Mazur J, Grzywacz A, Samochowiec J, Samochowiec A, Hajduk A, Bienkowski P. Haplotype analysis at DRD2 locus in patients with panic disorder. Psychiatry Res 2010; 179: 119-120
70. Deckert J, Nöthen MM, Franke P, Delmo C, Fritze J, Knapp M et al. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 1998; 3: 81-85
71. Hohoff C, Mullings EL, Heatherley SV, Freitag CM, Neumann LC, Domschke K et al. Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res 2010; 44: 930-937
72. Yamada K, Hattori E, Shimizu M, Sugaya A, Shibuya H, Yoshikawa T. Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 2001; 108: 837-848
73. Lam P, Hong CJ, Tsai SJ. Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci Lett 2005; 378: 98-101
74. Jensen KP, Stein MB, Kranzler HR, Yang BZ, Farrer LA, Gelernter J. The a-endomannosidase gene (MANEA) is associated with panic disorder and social anxiety disorder. Transl Psychiatry 2014; 4: e353
75. Ohara K, Suzuki Y, Ochiai M, Terada H. Polymorphism in the promoter region of the alpha(2A)-Adrenergic receptor gene and panic disorders. Psychiatry Res 2000; 93: 79-82
76. Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, Stepien G, Grzywacz A et al. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res 2004; 128: 21-26
77. Maron E, Lang A, Tasa G, Liivlaid L, Tru I, Must A et al. Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol 2005; 8: 261-266
78. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999; 8: 621-624
79. Tadic A, Rujescu D, Szegedi A, Giegling I, Singer P, Möller HJ et al. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet 2003; 117B: 1-6
80. Atasoy H, Güleç-Yilmaz S, Ergen A, Görmüs U, Küçükhüseyin Ö, Dalan B et al. Paraoxonase1 192 (PON1 192) gene polymorphism and serum paraoxonase activity in panic disorder patients. In Vivo 2015; 29: 51-54
81. Blaya C, Moorjani P, Salum GA, Gonçalves L, Weiss LA, Leistner-Segal S et al. Preliminary evidence of association between EFHC2, a gene implicated in fear recognition, and harm avoidance. Neurosci Lett 2009; 452: 84-86
82. Foldager L, Kohler O, Steffensen R, Thiel S, Kristensen AS, Jensenius JC et al. Bipolar and panic disorders may be associated with hereditary defects in the innate immune system. J Affect Disord 2014; 164: 148-154
83. Erhardt A, Lucae S, Unschuld PG, Ising M, Kern N, Salyakina D et al. Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. J Affect Disord 2007; 101: 159-168
84. Sand PG, Schlurmann K, Luckhaus C, Götz M, Stöber G, Lesch KP et al. Estrogen receptor 1 gene (ESR1) variants in panic disorder. Am J Med Genet 2002; 114: 426-428
85. Martínez-Barrondo S, Sáiz PA, Morales B, García-Portilla MP, Coto E, Alvarez V, Bascarán MT et al. Negative evidences in association between apolipoprotein E polymorphism and panic disorder. Eur Psychiatry 2006; 21: 59-61
86. Kobayashi Y, Akiyoshi J, Kanehisa M, Ichioka S, Tanaka Y, Tsuru J et al. Lack of polymorphism in genes encoding mGluR 7, mGluR 8, GABA(A) receptor alfa-6 subunit and nociceptin/orphanin FQ receptor and panic disorder. Psychiatr Genet 2007; 17: 9
87. Keck ME, Kern N, Erhardt A, Unschuld PG, Ising M, Salyakina D et al. Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1196-1204
88. Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, Krakowitzky P, Fritze J et al. Rgs 2 gene polymorphisms as modulators of anxiety in humans?. J Neural Transm 2006; 113: 1921-1925
89. Mouri K, Hishimoto A, Fukutake M, Nishiguchi N, Shirakawa O, Maeda K. Association study of RGS2 gene polymorphisms with panic disorder in Japanese. Kobe J Med Sci 2010; 55: e116-e121
90. Hohoff C, Weber H, Richter J, Domschke K, Zwanzger PM, Ohrmann P et al. RGS2 genetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety. Am J Med B Neuropsychiatr Genet 2015; 168: 211-222
91. Otowa T, Shimada T, Kawamura Y, Sugaya N, Yoshida E, Inoue K et al. Association of RGS2 variants with panic disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 430-434
92. Sand PG, Godau C, Riederer P, Peters C, Franke P, Nöthen MM et al. Exonic variants of the GABA(B) receptor gene and panic disorder. Psychiatr Genet 2000; 10: 191-194
93. Domschke K, Hohoff C, Jacob C, Maier W, Fritze J, Bandelow B et al. Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 510-516
94. Lindberg C, Koefoed P, Hansen ES, Bolwig TG, Rehfeld JF, Mellerup E et al. No association between the -399 C4T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population. Acta Psychiatr Scand 2006; 113: 54-58
95. Hohoff C, Neumann A, Domschke K, Jacob C, Maier W, Fritze J. Association analysis of Rgs7 variants with panic disorder. J Neural Transm 2009; 116: 1523-1528
96. Hettema JM, An SS, Neale MCBukszar J, van Den Oord EJ, Kendler KS et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 2006; 11: 752-762
97. Weber H, Scholz CJ, Domschke K, Baumann C, Klauke B, Jacob CP et al. Sex differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder. PLoS One 2012; 7: e37651
98. Thoeringer CK, Ripke S, Unschuld PG, Lucae S, Ising M, Bettecken T et al. The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. J Neural Transm 2009; 116: 649-657
99. Unschuld PG, Ising M, Erhardt A, Lucae S, Kohli M, Kloiber S et al. Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord 2008; 105: 177-184
100. Unschuld PG, Ising M, Roeske D, Erhardt A, Specht M, Kloiber S et al. Sex-specific association of galanin polymorphisms with HPA-Axis dysregulation, symptom severity, and antidepressant treatment response. Neuropsychopharmacology 2010; 35: 1583-1592
101. Buttenschøn HN, Kristensen AS, Buch HN, Andersen JH, Bonde JP, Grynderup M et al. The norepinephrine transporter gene is a candidate gene for panic disorder. J Neural Transm 2011; 118: 969-976
102. Lee YJ, Hohoff C, Domschke K, Sand P, Kuhlenbäumer G, Schirmacher A et al. Norepinephrine transporter (NET) promoter and 5'-UTR polymorphisms: association analysis in panic disorder. Neurosci Lett 2005; 377: 40-43
103. Sand PG, Mori T, Godau C, Stöber G, Flachenecker P, Franke P et al. Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci Lett 2002; 333: 41-44
104. Ishii T, Akiyoshi J, Hanada H, Ishitobi Y, Tanaka Y, Tsuru J et al. Association between the obestatin and BDNF gene polymorphism and panic disorder, and depressive disorder. Psychiatr Genet 2009; 19: 159
105. Shimizu E, Hashimoto K, Koizumi H, Kobayashi K, Itoh K, Mitsumori M et al. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 708-712
106. Otowa T, Shimada T, Kawamura Y, Liu X, Inoue K, Sugaya N et al. No association between the brain-derived neurotrophic factor gene and panic disorder in Japanese population. J Hum Genet 2009; 54: 437-439
107. Konishi Y, Tanii H, Otowa T, Sasaki T, Tochigi M, Umekage T et al. Gene õ gene õ sex interaction of BDNF and COMT genotypes associated with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014; 51: 119-125
108. Lam P, Cheng CY, Hong CJ, Tsai SJ. Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 2004; 49: 178-181
109. Han EJ, Kim YK, Hwang JA, Kim SH, Lee HJ, Yoon HK et al. Evidence for association between brain-derived neurotrophic factor gene and panic disorder: a novel haplotype analysis. Psychiatry Investig 2015; 12: 112-117
110. Hansson C, Annerbrink K, Nilsson S, Bah J, Olsson M, Allgulander C et al. A possible association between panic disorder and a polymorphism in the preproghrelingene. Psychiatry Res 2013; 206: 22-25
111. Nakashima K, Akiyoshi J, Hatano K, Hanada H, Tanaka Y, Tsuru J et al. Ghrelin gene polymorphism is associated with depression, but not panic disorder. Psychiatr Genet 2008; 18: 257
112. Blaya C, Salum GA, Moorjani P, Seganfredo AC, Heldt E, Leistner-Segal S et al. Panic disorder and serotonergic genes (SLC6A4, HTR1A and HTR2A): association and interaction with childhood trauma and parenting. Neurosci Lett 2010; 485: 11-15
113. Choe AY, Kim B, Lee KS, Lee JE, Lee JY, Choi TK et al. Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-by-environment interaction for panic disorder. Neuropsychobiology 2013; 67: 192-200
114. Martínez-Barrondo S, Saiz PA, Morales B, García-Portilla MP, Coto E, Alvarez V et al. Serotonin gene polymorphisms in patients with panic disorder. Actas Esp Psiquiatr 2005; 33: 210-215
115. Gyawali S, Subaran R, Weissman MM, Hershmowitz D, McKenna MC, Talati A et al. Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder. Biol Psychiatry 2010; 67: 331-338
116. Olesen OF, Bennike B, Hansen ES, Koefoed P, Woldbye DP, Bolwig TG et al. The short/long polymorphism in the serotonin transporter gene promoter is not associated with panic disorder in a Scandinavian sample. Psychiatr Genet 2005; 15: 159
117. Deckert J, Catalano M, Heils A, Di Bella D, Friess F, Politi E et al. Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet 1997; 7: 45-47
118. Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K. Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene. Psychiatry Res 1998; 81: 277-279
119. Matsushita S, Muramatsu T, Kimura M, Shirakawa O, Mita T, Nakai T et al. Serotonin transporter gene regulatory region polymorphism and panic disorder. Mol Psychiatry 1997; 2: 390-392
120. Kim W, Choi YH, Yoon KS, Cho DY, Pae CU, Woo JM. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1413-1418
121. Ishiguro H, Arinami T, Yamada K, Otsuka Y, Toru M, Shibuya H. An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population. Psychiatry Clin Neurosci 1997; 51: 333-335
122. Politi P, Minoretti P, Falcone C, Martinelli V, Emanuele E. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci Lett 2006; 396: 163-166
123. Armengol L, Gratacòs M, Pujana MA, Ribasés M, Martín-Santos R, Estivill X. 5' UTR-region SNP in the NTRK3 gene is associated with panic disorder. Mol Psychiatry 2002; 7: 928-930
124. Hattori E, Ebihara M, Yamada K, Ohba H, Shibuya H, Yoshikawa T. Identification of a compound short tandem repeat stretch in the 5'-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia. Mol Psychiatry 2001; 6: 465-470
125. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J et al. Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 1999; 4: 284-285
126. Koefoed P, Woldbye DP, Hansen TO, Hansen ES, Knudsen GM, Bolwig TG et al. Gene variations in the cholecystokinin system in patients with panic disorder. Psychiatr Genet 2010; 20: 59-64
127. Wang Z, Valdes J, Noyes R, Zoega T, Crowe RR. Possible association of adomschk cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. Am J Med Genet 1998; 81: 228-234
128. Hösing VG, Schirmacher A, Kuhlenbäumer G, Freitag C, Sand P, Schlesiger C et al. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J Neural Transm Suppl 2004; 68: 147-156
129. Bräuer D, Görgens H, Einsle F, Zimmermann K, Noack B, von Kannen S et al. Analysis of Stathmin gene variation in patients with panic disorder and agoraphobia. Psychiatr Genet 2013; 23: 43-44
130. Miyasaka K, Yoshida Y, Matsushita S, Higuchi S, Shirakawa O, Shimokata H et al. Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese. Am J Med Genet B Neuropsychiatr Genet 2004; 127B: 78-80
131. Ise K, Akiyoshi J, Horinouchi Y, Tsutsumi T, Isogawa K, Nagayama H. Association between the CCK-A receptor gene and panic disorder. Am J Med Genet B Neuropsychiatr Genet 2003; 118B: 29-31
132. Annerbrink K, Westberg L, Olsson M, Andersch S, Sjödin I, Holm G et al. Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene. Psychiatr Genet 2011; 21: 85-89
133. Kato T, Wang ZW, Zoega T, Crowe RR. Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder. Am J Med Genet 1996; 67: 401-405
134. Hattori E, Yamada K, Toyota T, Yoshitsugu K, Toru M, Shibuya H et al. Association studies of the CT repeat polymorphism in the 5' upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects. Am J Med Genet 2001; 105: 779-782
135. Steinlein OK, Deckert J, Nöthen MM, Franke P, Maier W, Beckmann H et al. Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study. Am J Med Genet 1997; 74: 199-201
136. Hettema JM, An SS, van Den Oord EJ, Neale MC, Kendler KS, Chen X. Association study between the serotonin 1 A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 661-666
137. Choi WS, Lee BH, Yang JC, Kim YK. Association study between 5-HT1A receptor gene C(-1019)G polymorphism and panic disorder in a Korean population. Psychiatry Investig 2010; 7: 141-146
138. Inada Y, Yoneda H, Koh J, Sakai J, Himei A, Kinoshita Y et al. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res 2003; 118: 25-31
139. Fehr C, Grintschuk N, Szegedi A, Anghelescu I, Klawe C, Singer P et al. The HTR1B 861G4C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Res 2000; 97: 1-10
140. Fehr C, Schleicher A, Szegedi A, Anghelescu I, Klawe C, Hiemke C et al. Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 965-982
141. Annerbrink K, Westberg L, Olsson M, Allgulander C, Andersch S, Sjödin I et al. Association between the catechol-O-methyltransferase Val158Met polymorphism and panic disorder: a replication. Psychiatry Res 2010; 178: 196-198
142. Domschke K, Freitag CM, Kuhlenbäumer G, Schirmacher A, Sand P, Nyhuis P et al. Association of the functional V158M catechol-O-methyl-Transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol 2004; 7: 183-188
143. Woo JM, Yoon KS, Yu BH. Catechol O-methyltransferase genetic polymorphism in panic disorder. Am J Psychiatry 2002; 159: 1785-1787
144. Woo JM, Yoon KS, Choi YH, Oh KS, Lee YS, Yu BH. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J Psychiatr Res 2004; 38: 365-370
145. Kang EH, Song YJ, Kim KJ, Shim HB, Park JE, Yu BH. Sympathetic nervous function and the effect of the catechol-O-methyltransferase Val(158)Met polymorphism in patients with panic disorder. J Affect Disord 2010; 123: 337-340
146. Kim B, Yoo E, Lee JY, Lee KS, Choe AY, Lee JE et al. The effects of the catechol-Omethyltransferase val158met polymorphism on white matter connectivity in patients with panic disorder. J Affect Disord 2013; 147: 64-71
147. Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K. No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res 1998; 80: 145-148
148. Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S et al. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 2006; 31: 2237-2242
149. Karacetin G, Bayoglu B, Cengiz M, Demir T, Kocabasoglu N, Uysal O et al. Serotonin-2A receptor and catechol-O-methyltransferase polymorphisms in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36: 5-10
150. Hettema JM, An SS, Bukszar J, van Den Oord EJ, Neale MC, Kendler KS et al. Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol Psychiatry 2008; 64: 302-310
151. Rothe C, Koszychi D, Bradwejn J, King B, De Luca V, Shaikh S et al. Association study of serotonin-2 A receptor gene polymorphism and panic disorder in patients from Canada and Germany. Neurosci Lett 2004; 363: 276-279
152. Unschuld PG, Ising M, Erhardt A, Lucae S, Kloiber S, Kohli M et al. Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 424-429
153. Yoon HK, Yang JC, Lee HJ, Kim YK. The association between serotonin-related gene polymorphisms and panic disorder. J Anxiety Disord 2008; 22: 1529-1534
154. Onodera M, Ishitobi Y, Tanaka Y, Aizawa S, Masuda K, Inoue A et al. Genetic association of the oxytocin receptor genes with panic, major depressive disorder, and social anxiety disorders. Psychiatr Genet 2015 (e-pub ahead of print
155. Domschke K, Kuhlenbäumer G, Schirmacher A, Lorenzi C, Armengol L, DiBella D et al. Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder. Am J Med Genet B Neuropsychiatr Genet 2003; 117B: 70-78
156. Fehr C, Szegedi A, Anghelescu I, Klawe C, Hiemke C, Dahmen N. Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatr Genet 2000; 10: 59-65
157. Deckert J, Meyer J, Catalano M, Bosi M, Sand P, DiBella D et al. Novel 5'-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. Int J Neuropsychopharmacol 2000; 3: 321-325
158. Nakamura K, Yamada K, Iwayama Y, Toyota T, Furukawa A, Takimoto T et al. Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 222-226
159. Mizuta N, Akiyoshi J, Sato A, Hanada H, Tanaka Y, Tsuru J et al. Serotonin receptor 3 A (HTR3A) gene is associated with personality traits, but not panic disorder. Psychiatr Genet 2008; 18: 44
160. Otowa T, Kawamura Y, Sugaya N, Yoshida E, Shimada T, Liu X et al. Association study of PDE4B with panic disorder in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 545-549
161. Mössner R, Freitag CM, Gutknecht L, Reif A, Tauber R, Franke P et al. The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder. J Psychopharmacol 2006; 20: 547-552
162. Maron E, Tru I, Must A, Tasa G, Toover E, Vasar V et al. Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci Lett 2007; 411: 180-184
163. Kim YK, Lee HJ, Yang JC, Hwang JA, Yoon HK. A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behav Genet 2009; 39: 170-175
164. Ishitobi Y, Nakayama S, Yamaguchi K, Kanehisa M, Higuma H, Maruyama Y et al. Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 429-436
165. Koido K, Eller T, Kingo K, Kks S, Traks T, Shlik J et al. Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. J Psychiatr Res 2010; 44: 275-277
166. Tharmalingam S, King N, De Luca V, Rothe C, Koszycki D, Bradwejn J et al. Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder. Psychiatr Genet 2006; 16: 93-97